,293,mitoparp,293 + low NAD,mitoparp + low NAD,subsystem
1PPDCRc_MitoCore,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
1PPDCRc_NADPH_MitoCore,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
2HBO,-0.017,-0.016999999999995453,-0.0109929328621879,-0.0109929328621908,Threonine and Methionine degradation
2HBt2,-0.016999999999995453,-0.017,-0.0109929328621879,-0.0109929328621908,Boundary Conditions - Biomarkers
2OXOADOXm,0.0,0.0,0.0,0.0,Tryptophan / Lysine Metabolism 
34HPPOR,0.0,0.0,0.0,0.0,Tyrosine degradation
3HBCOAHLm,0.0,0.0,0.0,0.0,Valine degradation
3SALATAi,0.0,0.0,0.0,0.0,Cysteine degradation I
3SPYRSP,0.0,0.0,0.0,0.0,Cysteine degradation I
4ABUTtm,0.0,0.0,0.0,0.0,GABA shunt - transport
4aabutn_MitoCore,0.0,0.0,0.0,0.0,Arginine degradation
5AOPtm,0.0,0.0,0.0,0.0,Haem Synthesis
AACTOORm_MitoCore,0.0,0.0,0.0,0.0,Glycine degradation
AASAD3m,0.0,0.0,0.0,0.0,Lysine degradation (saccharopine pathway)
ABTArm,0.0,0.0,0.0,0.0,GABA shunt
ABUTD,0.0,0.0,0.0,0.0,Ornithine degradation (cytosolic)
ACACT10m,0.0,0.0,0.0,0.0,Isoleucine degradation
ACACT1rm,-1.1984673913043478,-1.2463768115942033,-0.5604710494605727,-0.5813334675665875,FA and ketone body metabolism / Ketogenesis
ACACt2,0.0,0.0,0.0,0.0,Boundary conditions - core
ACACt2mB_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
ACADLC14_MitoCore,0.2841725407356587,0.2792392555862951,0.2449140731298522,0.20818472069813368,FA metabolism
ACADLC16_MitoCore,0.2841725407356587,0.27923925558629525,0.2449140731298522,0.20818472069813254,FA metabolism
ACALDtm,0.0,0.0,0.0,0.0,Alcohol metabolism
ACCOAC,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
ACCOALm,0.0,0.0,0.0,0.0,Propanoate metabolism
ACITL,0.0,0.0,0.0,0.0,Reductive carboxylation / Acetyl-CoA production for biosynthesis
ACITLm_MitoCore,0.0,0.0,0.0,0.0,TCA cycle periphery
ACOAHi,0.0,0.0,0.0,0.0,Acetate production
ACOATA,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
ACONT,-74.74622384710928,-74.65281676949134,-53.053464142657454,-49.300394676843545,Reductive carboxylation
ACONTm,-67.77798178482385,-67.82742546514343,-48.00622683585827,-44.32634909994693,TCA cycle
ACOT2_MitoCore,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
ACSm,0.0,0.0,0.0,0.0,Alcohol metabolism
ACt2r,0.0,-0.01,0.0,-0.01,Boundary Conditions - Biomarkers
ADK1,0.2842607946291196,0.28013726840869646,0.24491407312984137,0.2081847206981351,Cytosolic misc
ADK1m,0.0,0.0,0.0,0.0,TCA cycle periphery
ADNK1,0.0,0.0,0.0,0.0,Methionine degradation
ADSL1,0.0,0.0,0.0,0.0,Purine Nucleotide Cycle
ADSS,0.0,0.0,0.0,0.0,Purine Nucleotide Cycle
AGMTm,0.0,0.0,0.0,0.0,Arginine degradation
AHC,0.0,0.0,0.0,0.0,Methionine degradation
AKGDm,0.0,4.423488478764553,0.17455853830209075,2.722618507153346,TCA cycle
AKGMALtm,-0.6639999999999909,-4.052,-0.540582132617245,-2.243093959159793,Malate aspartate shuttle
AKGt_MitoCore,-1.918,-1.917999999999998,-1.3083018028323479,-1.6068343929806013,Boundary Conditions - Biomarkers
ALASm,0.0,0.0,0.0,0.0,Haem Synthesis
ALATA_L,-0.20299999999999563,-0.203,-0.20285882352941437,-0.20285882352941176,Cytosolic misc
ALAt2r,-0.311999999999986,-0.312,-0.25129106630861925,-0.2512910663086193,Boundary conditions - nonessential amino acids
ALCD2if,0.0,0.0,0.0,0.0,Alcohol metabolism
ALCD2yf,0.0,0.0,0.0,0.0,Alcohol metabolism
ALDD2x,0.0,0.0,0.0,0.0,Alcohol metabolism
ALDD2xm,0.0,0.0,0.0,0.0,Alcohol metabolism
AMCOXO,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
AMCOXO2_MitoCore,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
AMPD1,0.0,0.0,0.0,0.0,Purine Nucleotide Cycle
AMPTASECG,0.0,0.0,0.0,0.0,Glutathione degradation
AOBUTDsm,0.0,0.0,0.0,0.0,Glycine degradation
APAT2rm,0.0,0.0,0.0,0.0,Beta-alanine degradation
APRTO2m_MitoCore,0.0,0.0,0.0,0.0,Arginine degradation
ARGDCm,0.0,0.0,0.0,0.0,Arginine degradation
ARGN,0.0,0.0,0.0,0.0,Urea Cycle
ARGNm,0.0,0.0,0.0,0.0,Urea Cycle
ARGSL,-0.007,-0.007,-0.007,-0.007,Urea Cycle
ARGSS,0.0,0.0,0.0,0.0,Urea Cycle
ARGSUCt_MitoCore,-0.10966666666666566,-0.10966666666666669,-0.08943035543620892,-0.08943035543620677,Boundary Conditions - Biomarkers
ARGtiDF,-0.10266666666666516,-0.10266666666666668,-0.08243035543620536,-0.08243035543620929,Boundary conditions - nonessential amino acids
ARGtmB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
ASNS1,0.0,0.0,0.0,0.0,Asparagine synthesis
ASNtm,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
ASP1DC,0.0,0.0,0.0,0.0,Beta-alanine synthesis
ASPGLUmB_MitoCore,0.0,0.0,0.0,0.0,Malate aspartate shuttle
ASPTA,-0.158,-0.15799999999999997,-0.09729106630862516,-0.09729106630861925,Malate aspartate shuttle
ASPTAm,-4.443000000000065,-4.442999999999995,-4.09091919774834,-4.090919197748269,Malate aspartate shuttle
ASPte,-0.154,-0.154,-0.154,-0.154,Boundary conditions - nonessential amino acids
ATPtmB_MitoCore,-922.4167360230203,-920.5439776042731,-945.829326142073,-948.1047123298118,Mitochondrial transporters - characterised
BALAtmr,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
BDHm,0.0,0.0,0.0,0.0,Ketone bodies - degradation
BHBt,0.0,0.0,0.0,0.0,Boundary conditions - core
BHBtmB_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
BILIRED,0.0,0.0,0.0,0.0,Haem Degradation
BILIRED2_MitoCore,0.0,0.0,0.0,0.0,Haem Degradation
BUTt2mB_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
BUTt2r,0.0,0.0,0.0,0.0,Boundary conditions - alternative fuels
Biomass_MitoCore,-100.87424844203969,-100.88218482363732,-71.56378433296909,-66.49206883862075,Boundary conditions - core
Biomasst_MitoCore,-8.57264357830128,-0.009302325581395349,-5.35514015849039,-0.009302325581395349,Mitochondrial transport - diffusion / artificial
C160CPT1,0.28417254073565323,0.27923925558629537,0.24491407312984306,0.20818472069813368,Carnitine shuttle
C160CPT2,0.2841725407356587,0.27923925558629537,0.2449140731298522,0.20818472069813368,Carnitine shuttle
CBPSam,0.0,0.0,0.0,0.0,Citrulline biosynthesis
CDSm,0.0,0.0,0.0,0.0,Cardiolipin synthesis
CHLtmB_MitoCore,-3.086151688188598,0.0,-1.9278504570566382,0.0,Mitochondrial transporters - uncharacterised
CHOLtu,-3.0861516881885165,0.0,-1.9278504570566426,0.0,Boundary Conditions - Biomarkers
CIII_MitoCore,31.226572930108585,31.225937670897732,22.101768327157163,20.4261707298365,Electron transport chain
CII_MitoCore,3.9719897726842857,3.967987965532726,2.6907535273114003,2.176541942764035,Electron transport chain
CITtamB,-2.5559999999999956,-6.214285714285705,-2.439794147635892,-3.622095286919665,Mitochondrial transporters - characterised
CITtbm,-1.917999999999996,0.0,-1.9178588235294125,0.0,Mitochondrial transporters - characterised
CIV_MitoCore,15.613286465054342,15.612968835448866,11.050884163578667,10.21308536491825,Electron transport chain
CI_MitoCore,10.035054827288084,10.039586746913814,6.8451963397305295,6.718587016366688,Electron transport chain
CK,-922.4167360230207,-920.5439776042731,-945.8293261420727,-948.1047123298117,Creatine ATP buffer
CKc,-1000.0,-1000.0,-1000.0,-1000.0,Creatine ATP buffer
CLPN_MitoCore,-0.01,0.0,-0.01,0.0,Cardiolipin synthesis
CLS_hsm_MitoCore,0.0,0.0,0.0,0.0,Cardiolipin synthesis
CO2t,-18.346086956521933,-18.36417391304356,-13.461538465033966,-11.966066114290733,Boundary conditions - core
CO2tm,-18.423086956521953,-18.35633695652167,-12.42988344284874,-11.44660184448243,Mitochondrial transport - diffusion / artificial
COAtmB_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
COAtmC_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
COt,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
CPPPGO,0.0,0.0,0.0,0.0,Haem Synthesis
CREATtmdiffir,-922.4167360230202,-920.5439776042731,-945.8293261420728,-948.1047123298118,Mitochondrial transport - diffusion / artificial
CSm,5.2730148356441,5.283127665074408,3.6647627709523976,3.388221568519925,TCA cycle
CV_MitoCore,73.13698571015357,73.14316090238789,52.15013358021634,48.13908505152767,Electron transport chain
CYANt,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
CYANtm,0.0,0.0,0.0,0.0,Mitochondrial transport - diffusion / artificial
CYSTA,0.0,0.0,0.0,0.0,Cysteine degradation II
CYSTAm,0.0,0.0,0.0,0.0,Cysteine degradation II
CYSTGL,0.0,0.0,0.0,0.0,Methionine and Serine degradation
CYSTS,0.0,0.0,0.0,0.0,Methionine and Serine degradation
CYStec,-0.0049999999999954525,-0.005,-0.005,-0.005,Boundary conditions - nonessential amino acids
CYTK1m,0.0,0.0,0.0,0.0,Cardiolipin synthesis
DHFR,0.0,0.0,0.0,0.0,Folate cytosolic
DHPR,0.0,0.0,0.0,0.0,Phenylalanine degradation
ECOAH12m,0.0,0.0,0.0,0.0,Valine degradation
ECOAH1m,-1.036,-1.0843043478260919,-0.3981654174205221,-0.41902783552653744,FA metabolism
ECOAH9m,0.0,0.0,0.0,0.0,Isoleucine degradation
ENO,-1.1424999999999947,-0.3219999999999955,-0.22135492520295774,-0.26129106630861926,Glycolysis/gluconeogenesis
ETOHt,0.0,0.0,0.0,0.0,Boundary conditions - alternative fuels
FA160ACPH,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
FACOAL160i,0.28417254073565323,0.27923925558629537,0.24491407312984306,0.20818472069813154,Carnitine shuttle
FACOAL40im,0.0,0.0,0.0,0.0,Butanoate metabolism
FBA,0.0,0.0,0.0,0.0,Glycolysis/gluconeogenesis
FBP,0.0,0.0,0.0,0.0,Gluconeogenesis
FCLTm,0.0,0.0,0.0,0.0,Haem Synthesis
FE2t,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
FE2tm,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
FKYNH,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
FOLR2,0.0,0.0,0.0,0.0,Folate cytosolic
FOLt_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
FORt2mB_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
FORt_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
FTCD,0.0,0.0,0.0,0.0,Folate cytosolic
FTHFDH,0.0,0.0,0.0,0.0,Folate cytosolic
FTHFDHm_MitoCore,0.0,0.0,0.0,0.0,Folate mitochondrial
FTHFL,0.0,0.0,0.0,0.0,Folate cytosolic
FTHFLm,0.0,0.0,0.0,0.0,Folate mitochondrial
FUM,-1.8949999999999056,-1.8949999999999987,-1.6831541828751337,-1.8949999999999998,Cytosolic misc
FUMAC,0.0,0.0,0.0,0.0,Tyrosine degradation
FUMm,-34.186400193022074,-34.14463988768042,-24.2216530263808,-23.06144483238506,TCA cycle
FUMt_MitoCore,-1.918,-1.9179999999999995,-1.7060130064044816,-1.917858823529411,Boundary Conditions - Biomarkers
FUMtmB_MitoCore,-41.01480431159814,-41.01803119202793,-29.097362860658222,-27.035236780537684,Mitochondrial transporters - uncharacterised
G3PD1,-4.4329999999999945,-4.432999999999995,-4.081200887889126,-4.081200887889113,Glycerol phosphate shuttle
G5SADrm,-0.004,-0.004,-0.004,-0.004,Proline degradation/synthesis
G5SDym,0.0,0.0,0.0,0.0,Proline synthesis
G6PDH2r,0.0,0.0,0.0,0.0,Pentose phosphate pathway
G6PPer,0.0,0.0,0.0,0.0,Gluconeogenesis
GAPD,-0.8204999999999982,0.0,0.01605616457468173,0.0,Glycolysis/gluconeogenesis
GCCam,-0.34400000000000003,-0.34400000000000003,-0.1859063829787234,-0.1859063829787234,Glycine cleavage system (GCS)
GCCbim,-0.34400000000000003,-0.34400000000000003,-0.1859063829787234,-0.1859063829787234,Glycine cleavage system (GCS)
GCCcm,-0.34400000000000003,-0.34400000000000003,-0.1859063829787234,-0.1859063829787234,Glycine cleavage system (GCS)
GHMT2r,-0.01,-0.01,-0.009,-0.009,Serine and glycine biosynthesis
GHMT2rm,-0.13233333333333336,-0.34299999999999997,-0.0715163120567376,-0.1853659574468085,Serine and glycine biosynthesis
GLCt1r,0.0,0.0,0.009744124135455445,0.0,Boundary conditions - core
GLNS,0.0,0.0,0.0,0.0,Glutamine synthesis
GLNtm,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
GLU5Km,0.0,0.0,0.0,0.0,Proline synthesis
GLUCYS,0.0,0.0,0.0,0.0,Glutathione synthesis
GLUDC,0.0,0.0,0.0,0.0,GABA shunt
GLUDxi,0.0,0.0,0.0,0.0,Glutamate degradation/synthesis - cytosolic
GLUDxm,0.0,0.0,0.0,0.0,Glutamate degradation/synthesis
GLUDy,0.0,0.0,0.0,0.0,Glutamate degradation/synthesis - cytosolic
GLUDym,0.0,0.0,0.0,0.0,Glutamate degradation/synthesis
GLUN_MitoCore,0.0,0.0,0.0,0.0,Glutamine degradation - cytosolic
GLUNm,0.0,0.0,0.0,0.0,Glutamine degradation
GLUt2mB_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
GLUt_MitoCore,-0.32199999999999984,-0.322,-0.2612910663086203,-0.2612910663086193,Boundary conditions - nonessential amino acids
GLYC3Ptm,0.0,0.0,0.0,0.0,Cardiolipin synthesis
GLYCt,-0.01,-0.01,-0.01,-0.01,Boundary conditions - alternative fuels
GLYCtm,-1.4911794077386256,0.0,-0.9345627605001353,0.0,Mitochondrial transport - diffusion / artificial
GLYK,0.0,0.0,0.0,0.0,Cardiolipin synthesis
GLYOXm,0.0,0.0,0.0,0.0,Glycine degradation
GLYt2r,-0.678,-0.678,-0.4370710416883288,-0.4591974492873427,Boundary conditions - nonessential amino acids
GLYtm,-0.6880000000000001,-0.6879999999997968,-0.3718127659574468,-0.3718127659574468,Mitochondrial transporters - uncharacterised
GND,0.0,0.0,0.0,0.0,Pentose phosphate pathway
GPAMm_hsB_MitoCore,0.0,0.0,0.0,0.0,Cardiolipin synthesis
GTHO,0.0,0.0,0.0,0.0,ROS defense
GTHOm,0.01003505482728813,0.01003958674691377,0.006845196339732007,0.006718587016366748,ROS defense
GTHP,0.0,0.0,0.0,0.0,ROS defense
GTHPm,0.01003505482728813,0.01003958674691377,0.006845196339732007,0.006718587016366748,ROS defense
GTHS,0.0,0.0,0.0,0.0,Glutathione synthesis
GluForTx,0.0,0.0,0.0,0.0,Histidine degradation
H2Ot,-16.99573913043477,-17.01991304347827,-13.127618741121182,-12.040838704053773,Boundary Conditions - Misc
H2Otm,-135.46109030340878,-135.46436225368862,-97.7053979641769,-89.9245305277429,Mitochondrial transport - diffusion / artificial
HACD1m,-1.036,-1.0843043478260919,-0.3981654174205221,-0.41902783552653744,FA metabolism
HACD9m,0.0,0.0,0.0,0.0,Isoleucine degradation
HCO3t_MitoCore,0.0,0.0,0.0,0.0,Boundary conditions - core
HDCAtm_MitoCore,-0.7032446396410728,-0.708091207472804,-0.7418130216540834,-0.7911272496314026,Boundary conditions - core
HDCAtr,0.2841725407356587,0.2792392555862787,0.24491407312986102,0.1947174892830119,Boundary conditions - core
HEX1,0.0,0.0,0.00974412413546033,0.0,Glycolysis
HGNTOR,0.0,0.0,0.0,0.0,Tyrosine degradation
HIBDm,0.0,0.0,0.0,0.0,Valine degradation
HISD,0.0,0.0,0.0,0.0,Histidine degradation
HIStiDF,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
HKYNH,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
HMBS,0.0,0.0,0.0,0.0,Haem Synthesis
HMGCOASim,0.0,0.0,0.0,0.0,Ketogenesis
HMGLm,0.0,0.0,0.0,0.0,Ketogenesis / Leucine degradation
HOXG,0.0,0.0,0.0,0.0,Haem Degradation
Hct_MitoCore,-3.6901564782278546,-1.9091356029503872,-1.8797381956073627,-2.0028940377885056,Boundary Conditions - Misc
Hmt_MitoCore,-416.6650733884465,-416.5691818481032,-296.8689288975015,-275.07805975504795,Boundary Conditions - Misc
HtmB_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
ICDHxm,0.0,0.0,0.0,0.0,TCA cycle
ICDHy,-0.1,-0.1,-0.0962637362637363,-0.0962637362637363,Reductive carboxylation
ICDHyrm,-75.05917426191188,-2.2126406643662255,-53.817673603438436,-1.758232581617189,TCA cycle
ICITt_MitoCore,-1.9180000000000006,-1.9179999999999955,-1.1541747364954986,-1.4143764546481554,Boundary Conditions - Biomarkers
ILETAm,0.0,0.0,0.0,0.0,Isoleucine degradation
ILEt5m,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
ILEtec,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
IZPN,0.0,0.0,0.0,0.0,Histidine degradation
KYN3OX,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
LDH_Dm_MitoCore,0.0,0.0,0.0,0.0,Glycine degradation
LDH_L,-2.0554999999999892,-2.087499999999995,-1.329174911660769,-1.349867491166074,Glycolysis/gluconeogenesis
LEUTAm,0.0,0.0,0.0,0.0,Leucine degradation
LEUt5m,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
LEUtec,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
LGTHLm_MitoCore,0.0,0.0,0.0,0.0,Glycine degradation
LPCOXc_MitoCore,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
LYSOXc_MitoCore,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
LYStiDF,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
LYStmB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
L_LACt2r,-2.055500000000001,-2.087500000000076,-1.329174911660769,-1.349867491166074,Boundary conditions - core
MACACI,0.0,0.0,0.0,0.0,Tyrosine degradation
MALSO3tm,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
MALSO4tm,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
MALTSULtm,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
MAL_Lte,-1.9180000000000001,-1.918,-1.7060130064045058,-1.9178588235294134,Boundary Conditions - Biomarkers
MALtm,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
MCCCrm,0.0,0.0,0.0,0.0,Leucine degradation
MCLOR,-0.006,-0.0059999999999954525,-0.00387985865724173,-0.00387985865724382,Cysteine degradation II
MCOATA,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
MCPST,0.0,0.0,0.0,0.0,Cysteine degradation II
MCPSTm_MitoCore,0.0,0.0,0.0,0.0,Cysteine degradation II
MDH,-2.705,-2.705,-2.3457071827294937,-2.345707182729491,Malate aspartate shuttle
MDHm,3.80855321439416,3.8090076203974554,2.1892990320109114,1.8986708509750732,TCA cycle
ME1m,0.0,0.0,0.0,0.0,TCA cycle periphery
ME2,0.0,0.0,0.0,0.0,Cytosolic misc
ME2m,0.0,0.0,0.0,0.0,TCA cycle periphery
MECR14C_MitoCore,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
MECR16C_MitoCore,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
MERCPLACt_MitoCore,-0.0059999999999957865,-0.006,-0.00387985865724173,-0.00387985865724382,Boundary Conditions - Biomarkers
METAT,0.0,0.0,0.0,0.0,Methionine degradation
METAT2_MitoCore,0.0,0.0,0.0,0.0,Methionine degradation
METtec,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
MGCHrm,0.0,0.0,0.0,0.0,Leucine degradation
MMCDm,0.0,0.0,0.0,0.0,Propanoate synthesis
MMEm,0.0,-0.03199999999999559,0.0,-0.01376512114130731,Propanoate metabolism
MMMm,0.0,-1.9179999999999975,0.0,-1.5842222043481577,Propanoate metabolism
MMSAD1m,0.0,0.0,0.0,0.0,Propanoate metabolism
MMSAD3m,0.0,0.0,0.0,0.0,Beta-alanine degradation
MMSAD3m2_MitoCore,0.0,0.0,0.0,0.0,Beta-alanine degradation
MTHFC,0.0,0.0,0.0,0.0,Folate cytosolic
MTHFCm,0.0,0.0,0.0,0.0,Folate mitochondrial
MTHFD,-0.01,-0.01,-0.009,-0.009,Folate cytosolic
MTHFD2m,0.0,0.0,0.0,0.0,Folate mitochondrial
MTHFDm,0.0,0.0,0.0,0.0,Folate mitochondrial
MTPC14_MitoCore,0.2841725407356587,0.2792392555862951,0.2449140731298522,0.20818472069813368,FA metabolism
MTPC16_MitoCore,0.2841725407356587,0.2792392555862951,0.2449140731298522,0.20818472069813368,FA metabolism
NABTNOm,0.0,0.0,0.0,0.0,Arginine degradation
NADHt_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NADHtm_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NADt_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NADtm_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NDPK1,-3.7280000000001037,-1.81,-3.632595665634663,-1.714736842105263,Cytosolic misc
NDPK1m,-1000.0,0.0,-1000.0,0.0,TCA cycle periphery
NDPK3m,0.0,0.0,0.0,0.0,Cardiolipin synthesis
NH4t3r,-0.31400000000000006,-0.31400000000000006,-0.2532910663086191,-0.25329106630862097,Boundary Conditions - Biomarkers
NNT_MitoCore,0.0,0.0,0.0,0.0,TCA cycle periphery
NOS1,0.0,0.0,0.0,0.0,NOS Signalling
NOS2,0.0,0.0,0.0,0.0,NOS Signalling
NOt,-0.3219999999999956,-0.32199999999999307,-0.2612910663086192,-0.2612910663086194,Boundary Conditions - Misc
O2t,15.648742353897726,15.648415749582927,11.076158160212426,10.237314971543322,Boundary conditions - core
O2tm,15.637073798927641,15.636747194612841,11.067392766523904,10.228487710309208,Mitochondrial transport - diffusion / artificial
OAAt_MitoCore,-1.918000000000001,-1.9179999999999988,-1.9178588235294152,-1.9178588235294138,Boundary Conditions - Biomarkers
OCBTm,0.0,0.0,0.0,0.0,Citrulline biosynthesis
OCOAT1m,0.0,0.0,0.0,0.0,Ketone bodies - degradation
OF_ATP_MitoCore,80.69939875363183,80.7057478589096,57.25102746637582,53.19365507089717,Objective Function - ATP 
OF_HEME_MitoCore,0.0,0.0,0.0,0.0,Objective Function - Heme
OF_LIPID_MitoCore,0.0,0.0,0.0,0.0,Objective Function - Lipid synthesis 
OF_PROTEIN_MitoCore,0.0,0.0,0.0,0.0,Objective Function - Protein Synthesis
OIVD1m,0.0,0.0,0.0,0.0,Leucine degradation
OIVD2m,0.0,0.0,0.0,0.0,Valine degradation
OIVD3m,0.0,0.0,0.0,0.0,Isoleucine degradation
ORNDC,0.0,0.0,0.0,0.0,Ornithine degradation (cytosolic)
ORNTArm,-0.31500000000000006,-0.15400000000000003,-0.25429106630862186,-0.12364553315430965,Ornithine degradation
ORNt3mB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
ORNt4mB_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
P5CRm,0.0,0.0,0.0,0.0,Proline synthesis
P5CRxm,0.0,0.0,0.0,0.0,Proline synthesis
PCFLOPm,0.0,0.0,0.0,0.0,Mitochondrial transport - lipids
PCHOLHSTDe,-6.51520911950909,0.0,-4.069906520452903,0.0,Boundary Conditions - Lipids
PCHOLPm_hs,0.0,0.0,0.0,0.0,Cardiolipin synthesis
PCLAD,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
PCREATtmdiffirB_MitoCore,-922.4167360230202,-920.5439776042731,-945.8293261420728,-948.1047123298118,Mitochondrial transport - diffusion / artificial
PCm,0.0,0.0,0.0,0.0,TCA cycle periphery
PDHm,0.0,0.0,0.32569364812244994,0.0,TCA cycle
PEFLIPm,0.0,0.0,0.0,0.0,Mitochondrial transport - lipids
PEPCK,0.0,0.0,0.0,0.0,Gluconeogenesis
PEPCKm,0.0,0.0,0.0,0.0,TCA cycle periphery
PEt,0.0,0.0,0.0,0.0,Boundary Conditions - Lipids
PFK,0.0,0.0,0.0,0.0,Glycolysis
PGCD,0.0,0.0,0.0,0.0,Serine and glycine biosynthesis
PGI,-0.2513333333333255,0.0,-0.20894862296032524,0.0,Glycolysis/gluconeogenesis
PGK,-1.81,-1.81,-1.714736842105263,-1.714736842105263,Glycolysis/gluconeogenesis
PGL,0.0,0.0,0.0,0.0,Pentose phosphate pathway
PGM,-1.81,-1.81,-1.714736842105263,-1.714736842105263,Glycolysis/gluconeogenesis
PGPPTm,0.0,0.0,0.0,0.0,Cardiolipin synthesis
PGPP_hsm_MitoCore,0.0,0.0,0.0,0.0,Cardiolipin synthesis
PHEMEtm,0.0,0.0,0.0,0.0,Haem Synthesis
PHEtec,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
PIt2mB_MitoCore,-334.9762361457665,-334.9117752566225,-239.53450746154397,-221.65459460884313,Mitochondrial transporters - characterised
PPA,0.2842607946290907,0.2801372684086964,0.24491407312984112,0.20818472069813254,Carnitine shuttle
PPAm,0.0,0.0,0.0,0.0,Carnitine shuttle
PPAt,-0.03199999999999545,-1.9499999999999922,-0.013765121141308888,-1.5979873254894654,Boundary Conditions - Biomarkers
PPAtmB_MitoCore,-0.03199999999991962,-1.9499999999999433,-0.01376512114131103,-1.5979873254894024,Mitochondrial transporters - uncharacterised
PPCOACm,0.0,0.0,0.0,0.0,Propanoate metabolism
PPD2CSPc_MitoCore,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
PPPGOmB_MitoCore,0.0,0.0,0.0,0.0,Haem Synthesis
PROD2mB_MitoCore,0.0,0.0,0.0,0.0,Proline degradation
PROt2r,-0.3179999999999955,-0.31800000000000006,-0.2572910663086193,-0.2572910663086221,Boundary conditions - nonessential amino acids
PROtm,-0.3179999999999955,-0.31800000000011863,-0.25729106630862075,-0.25729106630851817,Mitochondrial transporters - uncharacterised
PSERT,0.0,0.0,0.0,0.0,Serine and glycine biosynthesis
PSFLIPm,0.0,0.0,0.0,0.0,Mitochondrial transport - lipids
PSP_L,0.0,0.0,0.0,0.0,Serine and glycine biosynthesis
PSt3,0.0,0.0,0.0,0.0,Boundary Conditions - Lipids
PTRCAT1m_MitoCore,0.0,0.0,0.0,0.0,Arginine degradation
PTRCOX1,0.0,0.0,0.0,0.0,Ornithine degradation (cytosolic)
PYK,0.0,0.0,0.0,0.0,Glycolysis/gluconeogenesis
PYRt2m,0.0,0.0,0.30218372661494186,0.0,Mitochondrial transporters - characterised
R03103_MitoCore,0.0,0.0,0.0,0.0,Lysine degradation (saccharopine pathway)
RE1254C,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
RE2649M,0.0,0.0,0.0,0.0,Propanoate synthesis
RPE,0.0,0.0,0.0,0.0,Pentose phosphate pathway
RPI,-0.12566666666666668,0.0,-0.10447431148016557,0.0,Pentose phosphate pathway
SACCD3m,0.0,0.0,0.0,0.0,Lysine degradation (saccharopine pathway)
SO3t_MitoCore,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
SPODMm,0.01003505482728813,0.010039586746913768,0.0068451963397318984,0.006718587016366748,ROS defense
SUCCt2m,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
SUCCt3m_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
SUCOAS1m,-1000.0,0.0,-1000.0,0.0,TCA cycle
SUCOASm,-1000.0,-7.243739130434781,-1000.0,-3.9737919481533335,TCA cycle
SUMt_MitoCore,-1.918000000000001,-1.9179999999999957,-1.5473911994410559,-1.7972500053892966,Boundary Conditions - Biomarkers
TALA,0.0,0.0,0.0,0.0,Pentose phosphate pathway
TCYNTt,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
TCYNTtmB_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transport - diffusion / artificial
THRD_L,0.0,0.0,0.0,0.0,Threonine degradation
TKT1,0.0,0.0,0.0,0.0,Pentose phosphate pathway
TKT2,0.0,0.0,0.0,0.0,Pentose phosphate pathway
TPI,-1.351650107202592,0.0,-0.29011811820738975,0.0,Glycolysis/gluconeogenesis
TRPO2,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
TRPt,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
TRPtm_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
TSULt_MitoCore,-0.0059999999999954525,-0.006,-0.006,-0.006,Boundary Conditions - Misc
TYRTA,-0.29900000000000004,-0.29899999999999055,-0.23843224277921005,-0.23843224277920747,Tyrosine degradation
TYRTB_MitoCore,0.0,0.0,0.0,0.0,Tyrosine degradation
TYRt,-0.012,-0.012,-0.0118588235294118,-0.0118588235294118,Boundary conditions - nonessential amino acids
UPPDC1,0.0,0.0,0.0,0.0,Haem Synthesis
URCN,0.0,0.0,0.0,0.0,Histidine degradation
UREAt,-0.3289999999999955,-0.329,-0.26829106630861876,-0.26829106630862254,Boundary Conditions - Biomarkers
UREAtm,-0.3289999999998372,-0.3289999999998372,-0.2682910663085259,-0.26829106630850674,Mitochondrial transporters - uncharacterised
VALTAm,0.0,0.0,0.0,0.0,Valine degradation
VALt5m,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
VALtec,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
r0060,0.0,0.0,0.0,0.0,Serine degradation
r0074,0.0,0.0,0.0,0.0,Proline / ornithine degradation
r0081,-414.704243595052,-414.73687094161886,-294.90382590829626,-273.3552830032213,TCA cycle periphery
r0122,0.0,0.0,0.0,0.0,Glycolysis
r0127,0.0,0.0,0.0,0.0,Asparagine degradation
r0129,0.0,0.0,0.0,0.0,Glutathione degradation
r0178,0.0,0.0,0.0,0.0,GABA shunt
r0193,0.0,0.0,0.0,0.0,Cysteine degradation III
r0205,0.0,0.0,0.0,0.0,Glycerol phosphate shuttle
r0226,0.0,0.0,0.0,0.0,Folate mitochondrial
r0287,0.284172540735659,0.2792392555862953,0.2449140731298522,0.20818472069813396,FA metabolism
r0399,0.0,0.0,0.0,0.0,Phenylalanine degradation
r0450,0.0,0.0,0.0,0.0,Lysine degradation (saccharopine pathway)
r0464c_MitoCore,0.0,0.0,0.0,0.0,Ornithine degradation (cytosolic)
r0514,0.0,0.0,0.0,0.0,Folate mitochondrial
r0525,0.0,0.0,0.0,0.0,Lysine degradation (saccharopine pathway)
r0541,0.0,0.0,0.0,0.0,Tryptophan / Lysine Metabolism 
r0560,0.0,0.0,0.0,0.0,Valine degradation
r0594,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
r0595B_MitoCore,0.0,0.0,0.0,0.0,Cysteine degradation II
r0595m_MitoCore,0.0,0.0,0.0,0.0,Cysteine degradation II
r0603,0.0,0.0,0.0,0.0,Isoleucine degradation
r0633,-16.45062872663827,-9.141912732421059,-4.284814924147645,-2.381149362863159,Fatty acid elongation in mitochondria
r0634,-1.0,-1.054391304347825,-0.3835616438356164,-0.4044240619416318,FA metabolism
r0638,-16.45062872663828,-9.141912732421059,-4.284814924147646,-2.381149362863159,Fatty acid elongation in mitochondria
r0645,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
r0655,0.0,0.0,0.0,0.0,Leucine degradation
r0660,-1.0,-1.0543913043478255,-0.3835616438356162,-0.4044240619416315,FA metabolism
r0678,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0681,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0682,0.0,-0.24428571428571427,0.0,-0.17932067199245763,FA synthesis - cytosolic
r0691,0.0,-0.24428571428571424,0.0,-0.17932067199245785,FA synthesis - cytosolic
r0692,0.0,-0.24428571428571427,0.0,-0.179320671992458,FA synthesis - cytosolic
r0693,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0694,0.0,-0.24428571428571427,0.0,-0.179320671992458,FA synthesis - cytosolic
r0695,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0696,0.0,-0.24428571428571433,0.0,-0.179320671992458,FA synthesis - cytosolic
r0697,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0701,0.0,-0.2442857142857143,0.0,-0.179320671992458,FA synthesis - cytosolic
r0702,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0712,0.0,-0.2442857142857143,0.0,-0.17932067199245721,FA synthesis - cytosolic
r0713,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0722,0.2841725407356588,0.2792392555862952,0.24491407312985186,0.20818472069813368,FA metabolism
r0724,-1.0,-1.0543913043478261,-0.3835616438356164,-0.4044240619416318,FA metabolism
r0726,0.28417254073565873,0.2792392555862951,0.2449140731298522,0.20818472069813396,FA metabolism
r0728,-1.0,-1.0543913043478277,-0.3835616438356162,-0.40442406194163194,FA metabolism
r0730,0.284172540735659,0.2792392555862952,0.2449140731298522,0.20818472069813396,FA metabolism
r0731,0.28417254073565873,0.27923925558629537,0.2449140731298522,0.20818472069813368,FA metabolism
r0732,0.284172540735659,0.2792392555862952,0.2449140731298522,0.20818472069813396,FA metabolism
r0733,0.284172540735659,0.2792392555862953,0.2449140731298522,0.20818472069813396,FA metabolism
r0734,0.284172540735659,0.2792392555862953,0.2449140731298522,0.20818472069813396,FA metabolism
r0735,-16.450628726638268,-9.141912732421059,-4.284814924147645,-2.381149362863159,Fatty acid elongation in mitochondria
r0760,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0761,0.0,-0.24428571428571427,0.0,-0.17932067199245721,FA synthesis - cytosolic
r0762,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0763,0.0,-0.24428571428571424,0.0,-0.17932067199245758,FA synthesis - cytosolic
r0764,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0765,0.0,-0.24428571428571427,0.0,-0.17932067199245721,FA synthesis - cytosolic
r0766,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0767,0.0,-0.24428571428571433,0.0,-0.17932067199245721,FA synthesis - cytosolic
r0768,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0769,0.0,-0.24428571428571433,0.0,-0.179320671992458,FA synthesis - cytosolic
r0770,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0771,0.0,-0.24428571428571433,0.0,-0.17932067199245721,FA synthesis - cytosolic
r0772,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0773,0.0,-0.24428571428571466,0.0,-0.17932067199245738,FA synthesis - cytosolic
r0791,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
r0817,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
r0829,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
r0830,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
r0830B_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
r0838B_MitoCore,-26.25051522469075,-26.22855443385182,-18.61441131327078,-17.358377348351,Mitochondrial transport - diffusion / artificial
r0899,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
r0913,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
r0917,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
r0917b_MitoCore,-74.64694384710955,-74.65281676949093,-52.957200406397305,-49.20413094057964,Mitochondrial transporters - characterised
r0940,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
r0941,0.0,0.0,0.0,0.0,Mitochondrial transport - diffusion / artificial
r0942,0.0,0.0,0.0,0.0,Boundary conditions - alternative fuels
r0942b_MitoCore,0.0,0.0,0.0,0.0,Boundary conditions - alternative fuels
r0962B_MitoCore,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
r1078,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
r1088,-1.9180000000000001,-1.9179999999999955,-1.1541747364954986,-1.4143764546481554,Boundary Conditions - Biomarkers
r1154,0.0,0.0,0.0,0.0,Threonine and Methionine degradation
r1155,0.0,0.0,0.0,0.0,Threonine degradation
r1423,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
r1427,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
r1434,-414.7042435950498,-414.73687094161534,-294.9038259083143,-273.35528300321187,Mitochondrial transporters - uncharacterised
r1435,-0.13233333333329855,-0.3429999999998964,-0.0715163120567376,-0.1853659574468085,Mitochondrial transporters - uncharacterised
r1436,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
r1437,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
r1440,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
r1446,0.28545906339708715,0.2805257782477244,0.246200595791281,0.2094712433595625,FA metabolism
r1447,0.2841725407356587,0.2792392555862951,0.2449140731298522,0.20818472069813368,FA metabolism
r1448,0.28417254073565873,0.2792392555862953,0.2449140731298522,0.20818472069813368,FA metabolism
r1450,0.284172540735659,0.2792392555862952,0.2449140731298522,0.20818472069813396,FA metabolism
r1451,0.2841725407356589,0.2792392555862953,0.24491407312985186,0.20818472069813368,FA metabolism
r1455,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
r1512,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
r2398B_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
r2402B_MitoCore,-1000.0,-1000.0,-1000.0,-1000.0,Mitochondrial transporters - characterised
r2435,0.2841725407356588,0.2792392555862953,0.2449140731298522,0.20818472069813254,Carnitine shuttle
r2525,-0.3219999999999999,-0.322,-0.26129106630862076,-0.2612910663086193,Boundary conditions - nonessential amino acids
r2526,-0.3265,-0.3265,-0.26529106630861926,-0.26529106630862,Boundary conditions - nonessential amino acids
r2532,-0.31199999999999545,-0.3119999999999996,-0.2512910663086193,-0.25129106630861886,Boundary conditions - nonessential amino acids
r2534,0.0,0.0,0.0,0.0,Boundary conditions - essential amino acids
